Cochrane Database of Systematic Reviews

Licence for publication:
Protocol for a Cochrane Review ("Protocol")

All authors must sign and date this form (or a separate copy for each author) and send the form(s) by post or fax, or scan and e-mail electronically, to the Managing Editor of the appropriate Cochrane Review Group.

Cochrane Review ID:

Cochrane Review title: No title found

Cochrane Review Group: No Group ID found

Author(s): No author(s) found

Authorship – I/we have made a substantial contribution to the conception and design of this Protocol. I/we have drafted the Protocol or commented on it critically for intellectual content. I/we have reviewed the final version of the Protocol and approve its validity for publication.

Cochrane Review Group approval – I/we acknowledge that, to be published in the Cochrane Database of Systematic Reviews, the Protocol must be approved by the CRG's Co-ordinating Editor or nominated deputy. The CRG's editorial team has the right to transfer responsibility for this Protocol to another CRG. The CRG has the right to withdraw the Protocol if the Cochrane Review does not meet the standards of the CRG and/or The Cochrane Collaboration, or if the Cochrane Review has not been completed within the pre-specified/agreed time frame.

For Diagnostic Test Accuracy Reviews only – I/we acknowledge that, to be published in the Cochrane Database of Systematic Reviews, the Protocol must be approved by the Cochrane Diagnostic Test Accuracy Editorial Team.

Licence for publication – I/we hereby grant to The Cochrane Collaboration for the full period of copyright and all extensions and renewals, an exclusive licence of the rights of copyright in and to the Protocol, including but not limited to the right to publish, re-publish, transmit, sell, distribute, and otherwise use the Protocol and the material contained therein in electronic editions of the Cochrane Database of Systematic Reviews, and print reprints thereof, and in derivative works, in all languages throughout the world, and to license or permit others to do so.

I/we represent that the Protocol is my/our original work. I am/we are the copyright owners of the Protocol or I am/we are expressly authorised by the copyright holder to grant this licence for publication. I/we warrant that the Protocol contains no libellous or unlawful statements and does not infringe the rights or privacy of others. I/we confirm that we have sought and obtained written permission from the copyright holders to use in the Protocol any excerpts from copyrighted works owned by third parties and have shown credit to the sources in the Protocol.

Authors' rights – In return for the grant of the licence, the author(s) shall have the following rights:

The author agrees that any and all copies of the Protocol or any part thereof distributed or posted by the author in print or electronic form will include the following form of acknowledgement and the relevant citation:

"This Protocol for a Cochrane Review is published in the Cochrane Database of Systematic Reviews 20XX, Issue X. Cochrane Protocols and Reviews are regularly updated as new evidence emerges and in response to feedback, and the Cochrane Database of Systematic Reviews should be consulted for the most recent version of the Protocol." Please include reference to the Protocol and hyperlink, to the original version using the following format: Authors. Title (Protocol). Cochrane Database of Systematic Reviews 20XX, Issue X. Art. No.: CD00XXXX. DOI: 10.1002/14651858.CD00XXXX (insert persistent link to the article by using the URL:http://dx.doi.org/10.1002/14651858.CD00XXXX). (This statement should refer to the most recent issue of the Cochrane Database of Systematic Reviews in which the Protocol appears.)

Permission to re-publish in forms not covered by the rights granted above may be sought from The Cochrane Collaboration's Publisher, John Wiley & Sons, Ltd (www.thecochranelibrary.com/view/0/PermissionsReprints.html); for example, permission to publish a version or excerpt of a Review in a print journal, online journal, or book.

Declaration of interest statement, as included in the Protocol

No declaration of interest statement found.

Author(s)

No author(s) found

☐ UK Government work (Crown Copyright)

Note to UK Government Employees:

The rights in a Cochrane Protocol prepared by an employee of a UK Government department, agency, or other Crown body as part of his/her official duties, or which is an official government publication, belong to the Crown.

For such cases, authors should refer to the following policy document and sample Crown copyright licence form:www.nationalarchives.gov.uk/documents/information-management/Publication_of_articles_written_by_ministers_and_civil_servants_PDF_FINAL.pdf. All authors should sign the sample Crown copyright licence form contained in the policy document or an appropriate licence from the relevant UK Government department, obtain a signature from the relevant UK Government department, and submit it to the Cochrane Review Group for a signature on behalf of The Cochrane Collaboration (the "Publisher" in the sample licence form). This Crown copyright licence is intended for previously unpublished work. If the content has already been published, then the terms of the Open Government Licence (www.nationalarchives.gov.uk/doc/open-government-licence/) apply and no separate licence is necessary.

The recommended wording to acknowledge the originating department and the copyright (one of the conditions) is "© Crown copyright [year of publication]. Reproduced with the permission of the Controller of Her Majesty's Stationery Office/Queen's Printer for Scotland and [name of Department]".

If the Cochrane Protocol is a work of mixed authorship of Crown and non-Crown employees, and is not a government work, only the Crown employees would sign the Crown copyright licence. The recommended wording to acknowledge the originating department and the copyright (one of the conditions) in this situation is "© [year of publication] The Cochrane Collaboration/Crown copyright. Reproduced with the permission of the Controller of Her Majesty's Stationery Office/Queen's Printer for Scotland and [name of Department]".

The signed Crown copyright licence form must be included with this Form. If you require assistance with this process, please contact your Managing Editor.

☐ US Government work

Note to US Government employees:

A Cochrane Protocol prepared by a US federal government employee as part of the employee's official duties, or which is an official US Government publication, is called a "US Government work", and is in the public domain in the United States of America. In such a case, the paragraph 'Licence for Publication' will not apply but she/he must still sign and return this Agreement. If the Cochrane Protocol was not prepared as part of the employee's duties or is not an official US Government publication, it is not US Government work.

National Institutes of Health (NIH) grantees

Pursuant to NIH mandate, John Wiley & Sons, Ltd will post the accepted version of contributions authored by NIH grant-holders to PubMed Central upon acceptance. This accepted version will be made publicly available 12 months after publication. For further information see www.wiley.com/go/nihmandate.

CRGs will alert the Senior Production Editor at John Wiley & Sons, Ltd when an NIH-funded Cochrane Review is marked for publication.

☐ Other Government work

Details should be sent to the Senior Production Editor at John Wiley & Sons, Ltd so that the necessary advice can be provided.

☐ World Health Organization (WHO) work

Note to World Health Organization (WHO) staff members:

A Cochrane Protocol prepared by a WHO staff member as part of the staff member's official duties belongs to WHO. For such cases, WHO has a standard agreement with John Wiley & Sons, Ltd. to vary certain provisions of this Form (including the grant of a non-exclusive licence). In such a case: (i) the paragraph 'Licence for Publication' will not apply but the staff member must still accept and submit this Agreement; and (ii) the staff member should make arrangements for their Director to sign the official addendum to this Form (contact Ian Coltart [coltarti@who.int] at WHO Press with any queries); and (iii) the WHO staff member shall then forward such addendum to Gavin Stewart, Associate Editor, John Wiley & Sons, Ltd (gstewart@wiley.com) to arrange for it to be countersigned and returned to the WHO staff member.

The addendum, signed by WHO and Wiley, must be included with this Form. If you require assistance with this process, please contact your Managing Editor.

Addendum to licence for publication of a World Health Organization (WHO) manuscript as a Cochrane Protocol or Review